Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) has announced its participation in the Wells Fargo 2024 Healthcare Conference in Boston on September 6, 2024. The company's corporate presentation is scheduled for 11:00 a.m. Eastern Time. Investors can access the live presentation through Vanda's corporate website, www.vandapharma.com, by following the link under Recent Events in the Investors tab. It is recommended that investors arrive at the conference website 15 minutes early to register and set up any necessary software. The archived conference will be available on Vanda's website for approximately 30 days after the event.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) ha annunciato la sua partecipazione alla Wells Fargo 2024 Healthcare Conference a Boston il 6 settembre 2024. La presentazione aziendale è programmata per le 11:00 a.m. ora orientale. Gli investitori possono accedere alla presentazione in diretta attraverso il sito web aziendale di Vanda, www.vandapharma.com, seguendo il link nella sezione Eventi Recenti del tab Investitori. Si raccomanda agli investitori di accedere al sito della conferenza 15 minuti prima per registrarsi e installare eventuali software necessari. La registrazione della conferenza sarà disponibile sul sito di Vanda per circa 30 giorni dopo l'evento.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) ha anunciado su participación en la Wells Fargo 2024 Healthcare Conference en Boston el 6 de septiembre de 2024. La presentación corporativa de la compañía está programada para las 11:00 a.m. hora del este. Los inversores pueden acceder a la presentación en vivo a través del sitio web corporativo de Vanda, www.vandapharma.com, siguiendo el enlace en la sección de Eventos Recientes en la pestaña de Inversores. Se recomienda a los inversores que lleguen al sitio de la conferencia 15 minutos antes para registrarse y configurar cualquier software necesario. La grabación de la conferencia estará disponible en el sitio web de Vanda durante aproximadamente 30 días después del evento.
반다 제약 주식회사(Nasdaq: VNDA)가 2024년 9월 6일 보스턴에서 개최되는 웰스 파고 2024 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 기업 발표는 동부 표준시 기준 오후 11:00에 예정되어 있습니다. 투자자들은 Vanda의 기업 웹사이트 www.vandapharma.com를 통해 최근 이벤트 섹션의 투자자 탭 아래 링크를 따라 라이브 발표에 접근할 수 있습니다. 투자자들은 등록 및 필요한 소프트웨어 설치를 위해 회의 웹사이트에 15분 일찍 도착할 것을 권장합니다. 회의 기록은 이벤트 종료 후 약 30일 동안 Vanda의 웹사이트에서 제공될 예정입니다.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) a annoncé sa participation à la Wells Fargo 2024 Healthcare Conference à Boston le 6 septembre 2024. La présentation de l'entreprise est prévue pour 11h00 heure de l'Est. Les investisseurs peuvent accéder à la présentation en direct via le site web de Vanda, www.vandapharma.com, en suivant le lien dans la section Événements Récents de l'onglet Investisseurs. Il est recommandé aux investisseurs d'arriver sur le site de la conférence 15 minutes plus tôt pour s'enregistrer et configurer tout logiciel nécessaire. L'enregistrement de la conférence sera disponible sur le site de Vanda pendant environ 30 jours après l'événement.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) hat seine Teilnahme an der Wells Fargo 2024 Healthcare Conference in Boston am 6. September 2024 bekannt gegeben. Die Unternehmenspräsentation ist für 11:00 Uhr Eastern Time geplant. Investoren können die Live-Präsentation über die Unternehmenswebsite von Vanda, www.vandapharma.com, über den Link im Bereich Aktuelle Veranstaltungen im Investorentab abrufen. Es wird empfohlen, dass Investoren 15 Minuten früher auf der Konferenzwebsite erscheinen, um sich zu registrieren und notwendige Software einzurichten. Die aufgezeichnete Konferenz wird für etwa 30 Tage nach der Veranstaltung auf Vandas Website verfügbar sein.
- None.
- None.
The corporate presentation given at the Wells Fargo 2024 Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-wells-fargo-2024-healthcare-conference-302234486.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) presenting at the Wells Fargo 2024 Healthcare Conference?
How can investors access Vanda Pharmaceuticals' (VNDA) presentation at the Wells Fargo 2024 Healthcare Conference?
For how long will the archived conference be available on Vanda Pharmaceuticals' (VNDA) website?
